Sartorius Stedim Biotech (SSB) and Refine Technology have entered into a collaboration to develop a robust platform for high-density cell cultivation. The goal of the platform is enable fast, easy connection of Refine’s ATF System with SSB’s single-use BIOSTAT bioreactors. “We decided to work together, based on market feedback, to create a better platform for late-stage clinical and commercial-scale biopharmaceutical manufacturing processes. Our objective is to give our customers the confidence...